Oxnard et al. recommended that any lung cancer patients with initial tumor tissue testing positive for EGFR T790M mutations should also have their peripheral blood samples retested to rule out the presence of germline mutations of EGFR T790M [33]. The gene discussed is EGFR; the disease is lung carcinoma.